Bepanthen MED, Nasensalbe
7680455350016
CH-45535
Nasensalbe
Associated product:
BEPANTHEN MED ong nasal 50 mg/g 2 tb 5 g
1 / 3
google
Article details
- Package size
- 2 x 5
- Selling units
- 2
- Measure
- g
- Galenic form
- Nasensalbe
- Galenic group
- Nasenmittel
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
100.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Bayer (Schweiz) AG
8045 Zürich
Authorization information
- Swissmedic authorization number
- 45535
- Drug name
- Bepanthen MED, Nasensalbe
- Galenic form
- NASA
- ATC Code
- R01AX10
- Authorization status
- Z
- Dispensing category
- D
- First authorization
- 08/09/1983
- Authorization expiration date
- 31/12/9999
- IT Number
- 12.02.4.
- Domain
- Human medicine
Package details
- Description (FR)
- BEPANTHEN MED ong nasal 50 mg/g 2 tb 5 g
- Description (DE)
- BEPANTHEN MED Nasensalbe 50 mg/g 2 Tb 5 g
- Market launch
- 08/09/1983
- Narcotic (BTM)
- No
Other package sizes (1)
BEPANTHEN ong nasal 2 tb 5 g
None None
GTIN: 7680455350290